Paropakar Maternity and Women's Hospital
Kathmandu, 44600, Nepal
NCT Number: NCT02727517
This study evaluates the hypothesis that delayed compared to early umbilical cord clamping will improve neonatal transition in terms of circulation and breathing during resuscitation.
Looking for future studies?
Notify Me33 week–42 week
All sexes
Interventional
Not applicable
Kathmandu, 44600, Nepal
At the time of birth, the infant is still attached to the placenta via the umbilical cord. The infant is usually separated from the placenta by clamping the cord with two clamps. Early cord clamping has been generally advised to be carried out in the first 30 seconds after birth, regardless of whether the cord pulsation has ceased. However, arguments against early cord clamping include the reduction in the amount of placental transfusion and any associated benefits of extra blood volume, as delayed clamping allows time for a transfer of the fetal blood in the placenta to the infant at the time of birth.
The study will evaluate the effect of early versus delayed cord clamping in a low-income setting in children that do not spontaneously start to breathe. The randomized controlled trial will be carried out at Paropakar Maternity and Women's Hospital (PMWH) in Kathmandu.
The trial will fill several important gaps in relation to early and delayed cord clamping and results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monochorionic twins (from an ultrasound scan) or clinical evidence of twin-twin transfusion syndrome, triplets or higher order multiple pregnancy, and fetuses with known congenital malformation
If the infant don't breathe, the umbilical cord is clamped (≤ 60 seconds) and cut and resuscitation will be provided at a resuscitation table
Other names: Immediate clamping
If the infant don't breathe, the umbilical cord is not clamped and cut until after 180 seconds. Initial resuscitation will be provided bedside to the mother
Other names: Late cord clamping, Deferred cord clamping, Optimal cord clamping
Time frame: 10 minutes after birth
Measured with a pulse oximeter
Time frame: 5 minutes after birth
Measured with a pulse oximeter
Time frame: Within 10 minutes after birth
Measured with a pulse oximeter
Time frame: At 1 minute after birth
Measured with a pulse oximeter (preferred), fetal heart monitor or manually
Time frame: At 5 minutes after birth
Measured with a pulse oximeter (preferred), fetal heart monitor or manually
Time frame: At 10 minutes after birth
Measured with a pulse oximeter (preferred), fetal heart monitor or manually
Time frame: At 1 minute after birth
Assessed by staff, composite of heart rate, breathing effort, skin color, muscle tone and reflexes
Time frame: At 5 minutes after birth
Assessed by staff, composite of heart rate, breathing effort, skin color, muscle tone and reflexes
Time frame: At 10 minutes after birth
Assessed by staff, composite of heart rate, breathing effort, skin color, muscle tone and reflexes
Time frame: At 5 minutes after birth
Measured with a pulse oximeter
Time frame: At 10 minutes after birth
Measured with a pulse oximeter
Time frame: Within 10 minutes after birth
Assessed by staff present
Time frame: Within 10 minutes after birth
Assessed by staff present
Time frame: Within 10 minutes after birth
Assessed by staff present
Time frame: At 30 minutes after birth
Assessed by staff present
Time frame: 24 hours
The place of stay for newborn at one day of age
Uppsala University
Other
Early or Late Cord Clamping in the Depressed Neonate - a Randomized Controlled Study in a Low-income Facility Setting for Improved Early Neonatal Outcome
Acronym: NepCordIII
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04366102
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Ambāla, Haryana, India
View Trial DetailsNCT01621373
Adverse Reaction to Drug, Chemically-Induced Disorders
Leuven, Vlaams Brabant, Belgium
View Trial DetailsNCT04271995
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
London, United Kingdom
View Trial DetailsNCT03706976
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Zurich, Canton of Zurich, Switzerland
View Trial Details